J.Thaddeus Beck, MD, FACP

Medical Oncologist

Beck

Dr. J. Thaddeus Beck is a founding physician and Medical Director of Highlands Oncology, where he has played a significant role in the growth and development of one of the country’s leading community-based oncology programs. Since co-founding Highlands Oncology in 1996 alongside Drs. Daniel Bradford and Malcolm Hayward, Dr. Beck has remained committed to expanding access to advanced cancer care and clinical research opportunities for patients in Northwest Arkansas and the surrounding region.

Dr. Beck has long been recognized for his expertise in oncology research and clinical trial development. Under his leadership, Highlands Oncology has developed one of the largest and most comprehensive community-based clinical trial programs in the nation, currently supporting more than 140 active clinical trials. Highlands is also home to Arkansas’ only community-based Phase I oncology clinical trial center.

Through years of collaboration with pharmaceutical and biotechnology companies around the world, Dr. Beck has helped to position Highlands Oncology as a respected research partner within the oncology community. Highlands’ patients have participated in numerous clinical trials involving therapies that later became commercially available treatment options, allowing patients in the region access to emerging therapies close to home.

Dr. Beck’s commitment to innovation has helped bridge the gap between community oncology and academic medicine. Patients often discover that clinical trial opportunities available at large academic institutions are also accessible at Highlands Oncology through the research program he helped establish.

In addition to his leadership in research, Dr. Beck remains actively involved in patient care and is known for his thoughtful, individualized approach to treatment planning. He works closely with patients to identify therapies and clinical trial opportunities that may be most appropriate for their specific diagnosis and needs.

He is also widely respected as a mentor and educator within Highlands Oncology’s research program, where he continues to support the development of physicians, nurses, clinical research professionals, and staff involved in advancing oncology care.

Dr. Beck earned his Doctor of Medicine from the University of Arkansas for Medical Sciences (UAMS), completed his residency in Internal Medicine at UAMS, and completed a fellowship in Hematology and Oncology at Duke University Medical School. He is board certified in Internal Medicine, Medical Oncology, and Hematology by the American Board of Internal Medicine and was elected a Fellow of the American College of Physicians in 2002.

Dr. Beck’s Role in Clinical Trials

Dr. Beck plays a vital role in advancing cancer treatment through his dedicated involvement in our Clinical Trials program.

Highlands

in the News

Our team is dedicated to staying at the forefront of oncology, and we are proud to share their latest advancements and recognition.

Surgeon highlights rising colorectal cancer cases among young adults

As March marks Colorectal Cancer Awareness Month, one doctor says he has seen an increase in cases in young adults.

According to the World Health Organization, colorectal cancer is now ranked as the third most common cancer worldwide and the second leading cause of cancer-related fatalities.

Highlands Oncology receives innovator award

Springdale-based Highlands Oncology, the region’s largest cancer-care provider, recently received a 2025 Association of Cancer Care Centers (ACCC) Innovator Award.

New cancer vaccine trial underway at Highlands Oncology in NW Arkansas

Some are calling it the research of the future — an mRNA vaccine to aid in cancer research.

There's an experimental trial for the vaccine that's been going on for the past year at Highlands Oncology in Springdale.

Simple, free, life-saving; Screening detects lung cancer early

As Joanna Thompson thinks back to the many lung cancer screenings she’s done over the years at Highlands Oncology in Springdale, one patient always springs to mind — the very first one whose screening revealed cancer in its early stages.